Feed MYX.AX
MY
Mayne Pharma Group Limited
MYX.AX · ASX
$3.24 +2.86% (+$0.09)
1M +11.31%
Market Cap $255.9M
P/E Ratio -
Div. Yield -
ROE 23.12%
Bulios Fair Price
$2.01
38.0% downside
Preț actual
$3.24
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile MYX.AX sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
67 /100
Cheap EV/EBITDA 5.64x
P/FCF 49.28x
P/S 0.63x
Growth
78 /100
Growing Rev. growth 37.45%
Book val. growth 12.14%
EPS growth N/A
Profitability
24 /100
Weak Gross margin 60.59%
FCF margin 1.27%
Net margin 22.99%
Quality
5 /100
Poor ROIC 3.22%
Asset turnover 0.40x
ROE 23.12%
Debt
74 /100
Low Debt/Equity 0.11x
Net debt/EBITDA -0.44x
Current ratio 1.35x
Stability
41 /100
Moderate Beta 1.00x
Profitable years 0
Rev. volatility 58.29%
Întreabă StockBot despre MYX.AX
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Aaron Gray
Employees
491
Headquarters
Salisbury South
Evenimente viitoare
27 AUG.
Earnings
Upcoming earnings report